Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Completed 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Dermatologic 6

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

3-ingenyl angelate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Melanosis × Clear all
NCT06079619 2024-04-05

Comparison of Dermatoscopy X400 Interpreted by 6 Non-dermatologists and an Artificial Intelligence Software Skin Artificial Intelligence Versus Dermatoscopy x 20

Centre Hospitalier Universitaire de Saint Etienne

Completed
157 enrolled
Dermatologic

Melanoma, Melanosis, Neoplasms, Nevus

NCT04834167 2023-11-30

OneDoc Picopulseâ„¢ for the Treatment of Melasma Among Malaysian Women

Universiti Tunku Abdul Rahman

Phase NA Completed
32 enrolled
Dermatologic

Melanoma, Melanosis, Skin Diseases

NCT01444989 2018-08-15

AKRQ

Wake Forest University Health Sciences

Phase NA Completed
150 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00375739 2016-01-28

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Peplin

Phase 2 Completed
200 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00107965 2015-03-25

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

Peplin

Phase 2 Completed
60 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Peplin

Phase 2 Completed
34 enrolled
Dermatologic

Keratosis, Melanosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡